Clinical Trial Update: A Phase II, International Open Label Trial of Minnelide™ in Patients With Refractory Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase II open-label trial of Minnelide in patients with refractory pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Minnelide (minnelide)

Snippet

Sponsor: Minneamrita Therapeutics LLC | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED